Key statistics dashboard for Edesa Biotech, Inc. (EDSA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate.
Stock Data
| Price | $3.87 |
| Market Cap | $37M |
| Enterprise Value | $26.9M |
| Beta | -0.68 |
| Exchange | NASDAQ |
| Country | CA |
Valuation Multiples
| P/E Ratio | -2.44 |
| Price / Book | 4.21 |
| P/S | 0.00 |
| EV/EBITDA | -1.88 |
| EV/Sales | 0.00 |
| EV/FCF | -3.01 |
| P/FCF | -4.43 |
| Earnings Yield | -40.46% |
| FCF Yield | -24.01% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -124.21% |
| Return on Assets | -110.85% |
| Return on Invested Capital | -166.02% |
| Return on Capital Employed | -166.02% |
Financial Health
| Current Ratio | 2.76 |
| Quick Ratio | 2.76 |
| Cash Ratio | 2.64 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 0.72 |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.98 |
| Cash per share | 1.15 |
| FCF per share | -0.99 |
| Tangible Book Value per share | 0.77 |
| Dividend per share | 0.00 |
Related companies: BRTX · COCP · DWTX · ERNA · EVGN · IMNN · IMRN
Explore sector: Healthcare · Biotechnology
More sections of EDSA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks